James L Sorensen
Overview
Explore the profile of James L Sorensen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
1337
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sorensen J, McCuistian C, Fokuo J, Del Pino H, Smith J, Elahi S, et al.
J Psychoactive Drugs
. 2024 Aug;
:1-10.
PMID: 39215391
Ethical issues arise frequently in the treatment of substance use disorders (SUD). Counselors need guidance to navigate ethical dilemmas but receive limited training in resolving ethical issues. To narrow the...
2.
Fokuo J, Hutman P, Gruber V, Masson C, Lum P, Bush D, et al.
J Psychoactive Drugs
. 2024 Apr;
:1-11.
PMID: 38646910
Stigma is a public health concern. Stigmatizing attitudes toward persons with substance use disorders (SUDs) can adversely impact clinical care and outcomes. Beliefs about SUD, prior experience and familiarity to...
3.
Bosley H, Pena J, Penn A, Sorensen J, Tierney M, Flentje A
Subst Abus
. 2023 Oct;
44(4):337-347.
PMID: 37902034
Background: Rates of cannabis use are increasing in the United States, likely as a result of changes in societal attitudes and expanding legalization. Although many patients report wanting to discuss...
4.
McCuistian C, Fokuo J, Smith J, Sorensen J, Arnold E
Subst Abuse
. 2023 Mar;
17:11782218231158338.
PMID: 36923068
Introduction: During the COVID-19 pandemic, substance use disorder (SUD) treatment settings experienced several abrupt changes, including decreased admissions, reduction in services, and modified requirements for medication for substance use disorder....
5.
Najavits L, Clark H, DiClemente C, Potenza M, Shaffer H, Sorensen J, et al.
Curr Treat Options Psychiatry
. 2022 Apr;
7(4):544-558.
PMID: 35444925
Purpose Of Review: Posttraumatic stress disorder (PTSD) commonly co-occurs with substance use disorder (SUD) and is challenging to treat. We review all behavioral therapy models with at least one randomized...
6.
Korthuis P, Cook R, Lum P, Waddell E, Tookes H, Vergara-Rodriguez P, et al.
Addiction
. 2022 Feb;
117(7):1961-1971.
PMID: 35129242
Background And Aim: Opioid agonist medications for treatment of opioid use disorder (OUD) can improve human immunodeficiency virus (HIV) outcomes and reduce opioid use. We tested whether outpatient antagonist treatment...
7.
Sorensen J, Van Draanen J, Shingle M
Am J Addict
. 2022 Feb;
31(2):148-151.
PMID: 35102629
Background And Objectives: Legalization of recreational cannabis is occurring across the United States, with some controversy. To understand the range of issues that can arise when such a policy change...
8.
Mitchell S, Harmon-Darrow C, Lertch E, Monico L, Kelly S, Sorensen J, et al.
J Subst Abuse Treat
. 2021 Jun;
127:108351.
PMID: 34134868
Background: Patient navigation has potential for assisting patients who initiate methadone during pretrial detention to enter and remain in treatment following release, but we know little about participants' experiences with...
9.
Zweben J, Sorensen J, Shingle M, Blazes C
J Addict Med
. 2020 Dec;
15(6):454-460.
PMID: 33323695
This paper offers a review and recommendations for clinicians working with patients interested in discontinuing opioid agonist treatment. As buprenorphine/naloxone has gained widespread acceptance for opioid addiction, many treatment providers...
10.
Stitzer M, Gukasyan N, Matheson T, Sorensen J, Feaster D, Duan R, et al.
Psychol Addict Behav
. 2019 Aug;
34(1):23-30.
PMID: 31436447
Substance use can interfere with HIV treatment. A previous multisite clinical trial (Metsch et al., 2016) tested 2 behavioral interventions designed to improve treatment engagement in people with comorbid HIV...